$SHC News

Sotera Health Announces Third-Quarter 2026 Earnings Release Date

JP Morgan Downgrades Sotera Health to Underweight, Announces $17 Price Target

Is Sotera Health (SHC) Still A Bargain After A 35% Gain?

Transcript: Sotera Health Q2 2026 Earnings Conference Call

Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers

Here’s Why Sotera Health Company (SHC) Surges 25% in Q2

Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Insider Selling: Michael Petras Jr Unloads $21.17M Of Sotera Health Stock

Research Tools & Consumables Stocks Q2 Recap: Benchmarking Sotera Health Company (NASDAQ:SHC)

Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?

Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions

Sotera Health (SHC) Q2 2026 Earnings Call Transcript

Insider Transaction: Michael Rutz Sells $2.83M Worth Of Sotera Health Shares

SHC Q2 Deep Dive: Broad-Based Growth, Leadership Transition, and Strategic Investments Shape Outlook

Sotera Health (SHC) Is Up 5.9% After Q2 Earnings Beat And Guidance Hike What’s Changed

Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25

Barclays Maintains Overweight on Sotera Health, Raises Price Target to $22

Piper Sandler Reiterates Overweight on Sotera Health, Raises Price Target to $25

JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18

Sotera Health Q2 Earnings Call Highlights